Full Text View
Tabular View
No Study Results Posted
Related Studies
Randomized Controlled Trial of Argatroban With tPA for Acute Stroke (ARTSS-2)
This study is currently recruiting participants.
Verified September 2012 by The University of Texas Health Science Center, Houston
Study NCT01464788   Information provided by The University of Texas Health Science Center, Houston

First Received on November 1, 2011.   Last Updated on September 24, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Ischemic Stroke
Additional conditions recognized in this trial
Cerebral Infarction
Stroke
More general conditions related to this trial
Brain Diseases
Brain Infarction
Brain Ischemia
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Nervous System Diseases
Vascular Diseases
Interventions listed in this trial
Argatroban
Additional drug interventions recognized in this trial
Tissue Plasminogen Activator
More general drug interventions related to this trial
Anticoagulants
Antithrombins
Cardiovascular Agents
Enzyme Inhibitors
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Platelet Aggregation Inhibitors
Protease Inhibitors
Serine Proteinase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Andrew Barreto


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services